Number of the records: 1

vemurafenib

SYS		d000077484
LBL		00000nz--a2200181n--4500
005		20250606222648.7
008		190101\|\|\|anznnbabn-----------\|-a\|a------
040		$b slo $a BA006 $d BA006
065		$a D02.065.884.919
065		$a D02.886.590.700.919
065		$a D03.633.100.473.936
066		$a 01 $c 03
150		$a vemurafenib $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo
450		$w v $a PLX 4032 $2 slo
450		$w v $a Zelboraf $2 slo
550		$7 sllk_us_auth*d000970 $Y Antineoplastic Agents $w P $a antineoplastiká
550		$7 sllk_us_auth*d047428 $Y Protein Kinase Inhibitors $w P $a inhibítory proteínkináz
665		$a 2019 (2010) $2 eng
680	9-	$i An indole sulfonamide compound and inhibitor of BRAF KINASES that is used for the treatment of unresectable or metastatic MELANOMA. $2 eng
750	-2	$a Vemurafenib $2 eng
980		$x M

Number of the records: 1